A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients

Reference

• Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351:1731-40; PMID:15496622; http://dx.doi.org/10.1056/NEJMoa040694
   PubMed Web of Science ®Google Scholar
• Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355:1114-23; PMID:16971718; http://dx.doi.org/10.1056/NEJMoa060829
   PubMed Web of Science ®Google Scholar
• Roh MS, Colangelo LH, O'Connell MJ, Yothers G, Deutsch M, Allegra CJ, Kahlenberg MS, Baez-Diaz L, Ursiny CS, Petrelli NJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009; 27:5124-30; PMID:19770376; http://dx.doi.org/10.1200/JCO.2009.22.0467
   PubMed Web of Science ®Google Scholar
• Minsky BD, Cohen AM, Kemeny N, Enker WE, Kelsen DP, Reichman B, Saltz L, Sigurdson ER, Frankel J. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J Clin Oncol 1992; 10:79-84; PMID:1727928
   PubMed Web of Science ®Google Scholar
• Mohiuddin M, Hayne M, Regine WF, Hanna N, Hagihara PF, McGrath P, Marks GM. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys 2000; 48:1075-80; PMID:11072165; http://dx.doi.org/10.1016/S0360-3016(00)00732-X
   PubMed Web of Science ®Google Scholar
• Smith FM, Reynolds JV, Miller N, Stephens RB, Kennedy MJ. Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy. Eur J Surg Oncol 2006; 32:55-64; PMID:16324817; http://dx.doi.org/10.1016/j.ejso.2005.09.010
   PubMed Web of Science ®Google Scholar
• Kuremsky JG, Tepper JE, McLeod HL. Biomarkers for response to neoadjuvant chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 2009; 74:673-88; PMID:19480968; http://dx.doi.org/10.1016/j.ijrobp.2009.03.003
   PubMed Web of Science ®Google Scholar
• Desch CE, Benson AB, 3rd, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Pfister DG, Virgo KS, Petrelli NJ. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005; 23:8512-9; PMID:16260687; http://dx.doi.org/10.1200/JCO.2005.04.0063
   PubMed Web of Science ®Google Scholar
• Watanabe T, Komuro Y, Kiyomatsu T, Kanazawa T, Kazama Y, Tanaka J, Tanaka T, Yamamoto Y, Shirane M, Muto T, et al. Prediction of sensitivity of rectal cancer cells in response to preoperative radiotherapy by DNA microarray analysis of gene expression profiles. Cancer Res 2006; 66:3370-4; PMID:16585155; http://dx.doi.org/10.1158/0008-5472.CAN-05-3834
   PubMed Web of Science ®Google Scholar
• Daemen A, Gevaert O, De Bie T, Debucquoy A, Machiels JP, De Moor B, Haustermans K. Integrating microarray and proteomics data to predict the response on cetuximab in patients with rectal cancer. Pac Symp Biocomput 2008:166-77; PMID:18229684
   PubMedGoogle Scholar
• Ghadimi BM, Grade M, Difilippantonio MJ, Varma S, Simon R, Montagna C, Fuzesi L, Langer C, Becker H, Liersch T, et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 2005; 23:1826-38; PMID:15774776; http://dx.doi.org/10.1200/JCO.2005.00.406
   PubMed Web of Science ®Google Scholar
• Rimkus C, Friederichs J, Boulesteix AL, Theisen J, Mages J, Becker K, Nekarda H, Rosenberg R, Janssen KP, Siewert JR. Microarray-based prediction of tumor response to neoadjuvant radiochemotherapy of patients with locally advanced rectal cancer. Clin Gastroenterol Hepatol 2008; 6:53-61; PMID:18166477; http://dx.doi.org/10.1016/j.cgh.2007.10.022
   PubMed Web of Science ®Google Scholar
• Kim IJ, Lim SB, Kang HC, Chang HJ, Ahn SA, Park HW, Jang SG, Park JH, Kim DY, Jung KH, et al. Microarray gene expression profiling for predicting complete response to preoperative chemoradiotherapy in patients with advanced rectal cancer. Dis Colon Rectum 2007; 50:1342-53; PMID:17665260; http://dx.doi.org/10.1007/s10350-007-277-7
   PubMed Web of Science ®Google Scholar
• Brettingham-Moore KH, Duong CP, Greenawalt DM, Heriot AG, Ellul J, Dow CA, Murray WK, Hicks RJ, Tjandra J, Chao M, et al. Pretreatment transcriptional profiling for predicting response to neoadjuvant chemoradiotherapy in rectal adenocarcinoma. Clin Cancer Res 17:3039-47; PMID:21224373; http://dx.doi.org/10.1158/1078-0432.CCR-10-2915
   PubMed Web of Science ®Google Scholar
• Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L, Williams J, Lengauer C, Kinzler KW, Vogelstein B. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. The Journal of clinical investigation 1999; 104:263-9; PMID:10430607; http://dx.doi.org/10.1172/JCI6863
   PubMed Web of Science ®Google Scholar
• Chung JY, Lu M, Yin Q, Lin SC, Wu H. Molecular basis for the unique specificity of TRAF6. Adv Exp Med Biol 2007; 597:122-30; PMID:17633022; http://dx.doi.org/10.1007/978-0-387-70630-6_10
   PubMed Web of Science ®Google Scholar
• Della Vittoria Scarpati G, Falcetta F, Carlomagno C, Ubezio P, Marchini S, De Stefano A, Singh VK, D'Incalci M, De Placido S, Pepe S. A Specific miRNA Signature Correlates with Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys 2012; 83(4):1113-9; PMID:22172905
   PubMed Web of Science ®Google Scholar
• Drebber U, Lay M, Wedemeyer I, Vallbohmer D, Bollschweiler E, Brabender J, Monig SP, Holscher AH, Dienes HP, Odenthal M. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. Int J Oncol 2011; 39:409-15; PMID:21567082
   PubMed Web of Science ®Google Scholar
• Garajova I, Svoboda M, Slaby O, Kocakova I, Fabian P, Kocak I, Vyzula R. ; Possibilities of resistance prediction to neoadjuvant concomitant chemoradiotherapy in the treatment algorithm of patients with rectal carcinoma. Klin Onkol 2008; 21:330-7; PMID:19382596
   PubMedGoogle Scholar
• Agostini M, Pucciarelli S, Calore F, Bedin C, Enzo M, Nitti D. miRNAs in colon and rectal cancer: A consensus for their true clinical value. Clin Chim Acta 2010; 411:1181-6; PMID:20452339; http://dx.doi.org/10.1016/j.cca.2010.05.002
   PubMed Web of Science ®Google Scholar
• Cecchin E, Agostini M, Pucciarelli S, De Paoli A, Canzonieri V, Sigon R, De Mattia E, Friso ML, Biason P, Visentin M, et al. Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy. The pharmacogenomics journal 2011; 11:214-26; PMID:20368715; http://dx.doi.org/10.1038/tpj.2010.25
   PubMed Web of Science ®Google Scholar
• Pratesi N, Mangoni M, Mancini I, Paiar F, Simi L, Livi L, Cassani S, Buglione M, Grisanti S, Almici C, et al. Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011; 99:356-61; PMID:21704413; http://dx.doi.org/10.1016/j.radonc.2011.05.062
   PubMed Web of Science ®Google Scholar
• Mangoni M, Bisanzi S, Carozzi F, Sani C, Biti G, Livi L, Barletta E, Costantini AS, Gorini G. Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients. International journal of radiation oncology, biology, physics 2011; 81:52-8; PMID:20708344; http://dx.doi.org/10.1016/j.ijrobp.2010.04.023
   PubMed Web of Science ®Google Scholar
• Vral A, Willems P, Claes K, Poppe B, Perletti G, Thierens H. Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity. Molecular medicine reports 2011; 4:901-12; PMID:21725594
   PubMed Web of Science ®Google Scholar
• Alsbeih G, El-Sebaie M, Al-Harbi N, Al-Hadyan K, Shoukri M, Al-Rajhi N. SNPs in genes implicated in radiation response are associated with radiotoxicity and evoke roles as predictive and prognostic biomarkers. Radiation oncology 2013; 8:125; PMID:23697595; http://dx.doi.org/10.1186/1748-717X-8-125
   PubMed Web of Science ®Google Scholar
• Curwen GB, Murphy S, Tawn EJ, Winther, JF, Boice, JD, Jr. A study of DNA damage recognition and repair gene polymorphisms in relation to cancer predisposition and G2 chromosomal radiosensitivity. Environmental and molecular mutagenesis 2011; 52:72-6; PMID:21113933; http://dx.doi.org/10.1002/em.20633
   PubMed Web of Science ®Google Scholar
• Farnebo L, Jerhammar F, Ceder R, Grafstrom RC, Vainikka L, Thunell L, Grenman R, Johansson AC, Roberg K. Combining factors on protein and gene level to predict radioresponse in head and neck cancer cell lines. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2011; 40:739-46; http://dx.doi.org/10.1111/j.1600-0714.2011.01036.x
   PubMed Web of Science ®Google Scholar
• Akcakaya P, Ekelund S, Kolosenko I, Caramuta S, Ozata DM, Xie H, Lindforss U, Olivecrona H, Lui WO. miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Int J Oncol 2011; 39:311-8; PMID:21573504
   PubMed Web of Science ®Google Scholar
• Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M. BioGRID: a general repository for interaction datasets. Nucleic acids research 2006; 34:D535-9; PMID:16381927; http://dx.doi.org/10.1093/nar/gkj109
   PubMed Web of Science ®Google Scholar
• Kerrien S, Alam-Faruque Y, Aranda B, Bancarz I, Bridge A, Derow C, Dimmer E, Feuermann M, Friedrichsen A, Huntley R, et al. IntAct–open source resource for molecular interaction data. Nucleic acids research 2007; 35:D561-5; PMID:17145710; http://dx.doi.org/10.1093/nar/gkl958
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, Meade TW. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010; 376:1741-50; PMID:20970847; http://dx.doi.org/10.1016/S0140-6736(10)61543-7
   PubMed Web of Science ®Google Scholar
• Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, Rodriguez L, Kakarala M, Carpenter PM, McLaren C, Meyskens FL, Jr., et al. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila) 2011; 4:354-64; PMID:21372035; http://dx.doi.org/10.1158/1940-6207.CAPR-10-0098
   PubMed Web of Science ®Google Scholar
• Sandur SK, Deorukhkar A, Pandey MK, Pabon AM, Shentu S, Guha S, Aggarwal BB, Krishnan S. Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity. Int J Radiat Oncol Biol Phys 2009; 75:534-42; PMID:19735878; http://dx.doi.org/10.1016/j.ijrobp.2009.06.034
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860-7; PMID:12490959; http://dx.doi.org/10.1038/nature01322
   PubMed Web of Science ®Google Scholar
• Gatza CE, Oh SY, Blobe GC. Roles for the type III TGF-beta receptor in human cancer. Cell Signal 2010; 22:1163-74; PMID:20153821; http://dx.doi.org/10.1016/j.cellsig.2010.01.016
   PubMed Web of Science ®Google Scholar
• Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994; 73:2680-6; PMID:8194005; http://dx.doi.org/10.1002/1097-0142(19940601)73:11%3c2680::AID-CNCR2820731105%3e3.0.CO;2-C
   PubMed Web of Science ®Google Scholar
• Beddy D, Hyland JM, Winter DC, Lim C, White A, Moriarty M, Armstrong J, Fennelly D, Gibbons D, Sheahan K. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol 2008; 15:3471-7; PMID:18846402; http://dx.doi.org/10.1245/s10434-008-0149-y
   PubMed Web of Science ®Google Scholar
• Ryan R, Gibbons D, Hyland JM, Treanor D, White A, Mulcahy HE, O'Donoghue DP, Moriarty M, Fennelly D, Sheahan K. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005; 47:141-6; PMID:16045774; http://dx.doi.org/10.1111/j.1365-2559.2005.02176.x
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003; 31:e15; PMID:12582260; http://dx.doi.org/10.1093/nar/gng015
   PubMed Web of Science ®Google Scholar
• Hwang JT, Liu P. Optimal tests shrinking both means and variances applicable to microarray data analysis. Stat Appl Genet Mol Biol 2010; 9:Article36; PMID:20887275
   PubMed Web of Science ®Google Scholar
• Marchet A, Mocellin S, Belluco C, Ambrosi A, DeMarchi F, Mammano E, Digito M, Leon A, D'Arrigo A, Lise M, et al. Gene expression profile of primary gastric cancer: towards the prediction of lymph node status. Ann Surg Oncol 2007; 14:1058-64; PMID:17106627; http://dx.doi.org/10.1245/s10434-006-9090-0
   PubMed Web of Science ®Google Scholar
• Ntzani EE, Ioannidis JP. Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment. Lancet 2003; 362:1439-44; PMID:14602436; http://dx.doi.org/10.1016/S0140-6736(03)14686-7
   PubMed Web of Science ®Google Scholar
• Simon R, Radmacher MD, Dobbin K, McShane LM. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 2003; 95:14-8; PMID:12509396; http://dx.doi.org/10.1093/jnci/95.1.14
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Esposito G, Pucciarelli S, Alaggio R, Giacomelli L, Marchiori E, Iaderosa GA, Friso ML, Toppan P, Chieco-Bianchi L, Lise M. P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer. Annals of surgical oncology 2001; 8:311-8; PMID:11352304; http://dx.doi.org/10.1007/s10434-001-0311-2
   PubMed Web of Science ®Google Scholar
• Brown KR, Jurisica I. Online predicted human interaction database. Bioinformatics 2005; 21:2076-82; PMID:15657099; http://dx.doi.org/10.1093/bioinformatics/bti273
   PubMed Web of Science ®Google Scholar
• Brown KR, Otasek D, Ali M, McGuffin MJ, Xie W, Devani B, Toch IL, Jurisica I. NAViGaTOR: Network Analysis, Visualization and Graphing Toronto. Bioinformatics 2009; 25:3327-9; PMID:19837718; http://dx.doi.org/10.1093/bioinformatics/btp595
   PubMed Web of Science ®Google Scholar
• Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4:44-57; PMID:19131956; http://dx.doi.org/10.1038/nprot.2008.211
   PubMed Web of Science ®Google Scholar
• Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009; 37:1-13; PMID:19033363; http://dx.doi.org/10.1093/nar/gkn923
   PubMed Web of Science ®Google Scholar
• Shirdel EA, Xie W, Mak TW, Jurisica I. NAViGaTing the micronome–using multiple microRNA prediction databases to identify signalling pathway-associated microRNAs. PLoS One 2011; 6:e17429; PMID:21364759; http://dx.doi.org/10.1371/journal.pone.0017429
   PubMed Web of Science ®Google Scholar
• Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, et al. DrugBank 3.0: a comprehensive resource for ‘omics’ research on drugs. Nucleic Acids Res 2011; 39:D1035-41; PMID:21059682; http://dx.doi.org/10.1093/nar/gkq1126
   PubMed Web of Science ®Google Scholar